DJO Global Announces US Commercial Leadership Transition
SAN DIEGO, CA, - September 30, 2011 - DJO Global, Inc., (“DJO” or the “Company”) a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that Andrew Holman, executive vice president, U.S. commercial operations, is leaving DJO to pursue other opportunities. In connection with this transition and for the immediate future, DJO president and chief executive officer, Mike Mogul, will assume direct responsibility for DJO’s commercial activities in the United States.
“In the three months since I joined DJO, I have become increasingly optimistic about the depth and breadth of opportunities available to add value to our customers and to accelerate DJO’s revenue growth,” said Mike Mogul. “We see many opportunities to improve commercial execution, to develop new products and services and to expand our market penetration with our strong portfolio and commercial footprint.”
The Company also announced that it has taken steps to reduce its operating expenses to better match current global market conditions and to make funds available to invest in future growth opportunities.
About DJO Global
DJO Global is a leading global developer, manufacturer and distributor of high-quality medical devices and services that provide solutions for musculoskeletal health, vascular health and pain management. The Company’s products address the continuum of patient care from injury prevention to rehabilitation after surgery, injury or from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers and other healthcare professionals. In addition, many of the Company’s medical devices and related accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. The Company’s product lines include rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management and physical therapy products. The Company’s surgical division offers a comprehensive suite of reconstructive joint products for the hip, knee and shoulder. DJO Global’s products are marketed under a portfolio of brands including Aircast®, Chattanooga, CMF™, Compex®, DonJoy®, Empi®, ProCare®, DJO® Surgical and Dr. Comfort®. For additional information on the Company, please visit www.DJOglobal.com.
DJO Investor/Media Contact:
DJO Global, Inc.
Matt Simons, SVP Business Development and Investor Relations
760.734.5548
